Clinical Outcomes of Hydroxychloroquine in Hospitalized Patients with COVID-19: A Quasi-Randomized Comparative Study

Conclusion: Hydroxychloroquine administration to the hospitalized SARSCoV-2 positive population was associated with an increased need for escalation of respiratory support. There were no benefits of hydroxychloroquine on mortality, lymphopenia, or neutrophil-tolymphocyte ratio improvement.

Check Also

Modelo para la estimación de costos de la gestión de residuos reciclables con inclusión de recicladores

Herramienta para el análisis de costos asociados a diferentes niveles de inclusión de recicladores, de …

Deixe uma resposta

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *